§ 40-21-1. Prescription drug program.
The department of human services is hereby authorized and directed to amend its practices,
procedures, regulations, and the Rhode Island state plan for medical assistance (Medicaid)
pursuant to Title XIX of the federal Social Security Act, 42 U.S.C. §â€‚1396 et seq., to modify the prescription drug program:
(1) To establish a preferred drug list (PDL);
(2) To enter into supplemental rebate, discount, or other agreements with pharmaceutical
companies;
(3) To negotiate either state-specific supplemental r
Free access — add to your briefcase to read the full text and ask questions with AI
§ 40-21-1. Prescription drug program.
The department of human services is hereby authorized and directed to amend its practices,
procedures, regulations, and the Rhode Island state plan for medical assistance (Medicaid)
pursuant to Title XIX of the federal Social Security Act, 42 U.S.C. §â€‚1396 et seq., to modify the prescription drug program:
(1) To establish a preferred drug list (PDL);
(2) To enter into supplemental rebate, discount, or other agreements with pharmaceutical
companies;
(3) To negotiate either state-specific supplemental rebates or to participate in a multistate
pooling, supplemental-rebate program.
Determinations of drugs included on the PDL will be made by the State Department of
Human Services, and a listing of the drugs shall be maintained on a public website.
In making these determinations, the department shall consider the recommendations
of the Medicaid Pharmaceutical and Therapeutics Committee, whose membership shall
include practicing pharmacists and physicians, faculty members of the University of
Rhode Island's College of Pharmacy, and consumers or consumer representatives. Drugs
exempt from the PDL shall include: (i) Anti-retrovirals; and (ii) Organ transplant
medications. Physicians will be informed about prior authorization procedures for
medications not on the PDL, and seventy-two-hour (72) emergency supplies may be dispensed
if authorizations cannot be obtained; and
(4) To mandate the dispensing of generic-only drugs with the exception of limited-brand
drug coverage for certain therapeutic classes as approved by the Department of Human
Services to individuals eligible for medical assistance (Medicaid) under §§â€‚40-8.4-4, 42-12.3-4 and 42-12.3-15.